Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
RBC Captial analyst Mark Mahaney maintained an Outperform rating on Facebook Inc. (NASDAQ:FB) and slightly reduced the price target to $90 (from $92 – …
